$ Value
$0
Shares
115,000
Price
$0
Filed
Mar 18
Insider
Name
Berg Edward B
Title
SVP, General Counsel
CIK
0001912178
Roles
Transaction Details
Transaction Date
2026-03-16
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
799,858
Footnotes
Grant of shares upon vesting of restricted stock units. 25% of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 16, 2026, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. | The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 16, 2027, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 16, 2030.
Filing Info
Berg Edward B's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-24 | VXRT | F | $25K |
| 2026-03-18 | VXRT | F | $5K |
| 2026-03-16 | VXRT | A | $0 |
| 2026-03-16 | VXRT | A | $0 |
| 2026-02-02 | VXRT | F | $6K |
Other Insiders at VXRT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Lo Steven
President, Chief Exec Officer
|
— | — | 2026-03-24 |
|
Tucker Sean
SVP, Chief Scientific Officer
|
— | — | 2026-03-28 |
|
Cummings James F.
Chief Medical Officer
|
— | — | 2026-03-28 |
|
Berg Edward B
SVP, General Counsel
|
— | — | 2026-03-24 |
|
Grasman Jeroen Nicolaas
Chief Financial Officer
|
— | — | 2026-03-16 |